Valentina Scheggi1, Irene Merilli2, Rossella Marcucci3, Stefano Del Pace3, Iacopo Olivotto3, Nicola Zoppetti4, Nicole Ceschia3, Valentina Andrei3, Bruno Alterini2, Pier Luigi Stefàno5, Niccolò Marchionni3. 1. Division of Cardiovascular and Perioperative Medicine, Cardiothoracovascular Department, Azienda Ospedaliero-Universitaria Careggi and University of Florence, Largo Brambilla 3, 50143, Florence, Italy. scheggiv@aou-careggi.toscana.it. 2. Division of Cardiovascular and Perioperative Medicine, Cardiothoracovascular Department, Azienda Ospedaliero-Universitaria Careggi and University of Florence, Largo Brambilla 3, 50143, Florence, Italy. 3. Division of General Cardiology, Cardiothoracovascular Department, Azienda Ospedaliero-Universitaria Careggi and University of Florence, Florence, Italy. 4. Institute of Applied Physics "Nello Carrara" (IFAC), National Research Council, Sesto Fiorentino, Italy. 5. Division of Cardiac Surgery, Cardiothoracovascular Department, Azienda Ospedaliero-Universitaria Careggi and University of Florence, Florence, Italy.
Abstract
PURPOSE: Mortality in infective endocarditis (IE) is still high, and the long term prognosis remains uncertain. This study aimed to identify predictors of long-term mortality for any cause, adverse event rate, relapse rate, valvular and ventricular dysfunction at follow-up, in a real-world surgical centre. METHODS: We retrospectively analyzed 363 consecutive episodes of IE (123 women, 34%) admitted to our department with a definite diagnosis of non-device-related IE. Median follow-up duration was 2.9 years. Primary endpoints were predictors of mortality, recurrent endocarditis, and major non-fatal adverse events (hospitalization for any cardiovascular cause, pace-maker implantation, new onset of atrial fibrillation, sternal dehiscence), and ventricular and valvular dysfunction at follow-up. RESULTS: Multivariate analysis independent predictors of mortality showed age (HR per unit 1.031, p < 0.003), drug abuse (HR 3.5, p < 0.002), EUROSCORE II (HR per unit 1.017, p < 0.0006) and double valve infection (HR 2.3, p < 0.001) to be independent predictors of mortality, while streptococcal infection remained associated with a better prognosis (HR 0.5, p < 0.04). Major non-fatal adverse events were associated with age (HR 1.4, p < 0.022). New episodes of infection were correlated with S aureus infection (HR 4.8, p < 0.001), right-sided endocarditis (HR 7.4, p < 0.001), spondylodiscitis (HR 6.8, p < 0.004) and intravenous drug abuse (HR 10.3, p < 0.001). After multivariate analysis, only drug abuse was an independent predictor of new episodes of endocarditis (HR 8.5, p < 0.001). Echocardiographic follow-up, available in 95 cases, showed a worsening of left ventricular systolic function (p < 0.007); severe valvular dysfunction at follow-up was reported only in 4 patients, all of them had mitral IE (p < 0.03). CONCLUSIONS: The present study highlights some clinical, readily available factors that can be useful to stratify the prognosis of patients with IE.
PURPOSE:Mortality in infective endocarditis (IE) is still high, and the long term prognosis remains uncertain. This study aimed to identify predictors of long-term mortality for any cause, adverse event rate, relapse rate, valvular and ventricular dysfunction at follow-up, in a real-world surgical centre. METHODS: We retrospectively analyzed 363 consecutive episodes of IE (123 women, 34%) admitted to our department with a definite diagnosis of non-device-related IE. Median follow-up duration was 2.9 years. Primary endpoints were predictors of mortality, recurrent endocarditis, and major non-fatal adverse events (hospitalization for any cardiovascular cause, pace-maker implantation, new onset of atrial fibrillation, sternal dehiscence), and ventricular and valvular dysfunction at follow-up. RESULTS: Multivariate analysis independent predictors of mortality showed age (HR per unit 1.031, p < 0.003), drug abuse (HR 3.5, p < 0.002), EUROSCORE II (HR per unit 1.017, p < 0.0006) and double valve infection (HR 2.3, p < 0.001) to be independent predictors of mortality, while streptococcal infection remained associated with a better prognosis (HR 0.5, p < 0.04). Major non-fatal adverse events were associated with age (HR 1.4, p < 0.022). New episodes of infection were correlated with S aureus infection (HR 4.8, p < 0.001), right-sided endocarditis (HR 7.4, p < 0.001), spondylodiscitis (HR 6.8, p < 0.004) and intravenous drug abuse (HR 10.3, p < 0.001). After multivariate analysis, only drug abuse was an independent predictor of new episodes of endocarditis (HR 8.5, p < 0.001). Echocardiographic follow-up, available in 95 cases, showed a worsening of left ventricular systolic function (p < 0.007); severe valvular dysfunction at follow-up was reported only in 4 patients, all of them had mitral IE (p < 0.03). CONCLUSIONS: The present study highlights some clinical, readily available factors that can be useful to stratify the prognosis of patients with IE.
Authors: Thomas J Cahill; Larry M Baddour; Gilbert Habib; Bruno Hoen; Erwan Salaun; Gosta B Pettersson; Hans Joachim Schäfers; Bernard D Prendergast Journal: J Am Coll Cardiol Date: 2017-01-24 Impact factor: 24.094
Authors: C Selton-Suty; B Hoen; A Grentzinger; P Houplon; M Maignan; Y Juillière; N Danchin; P Canton; F Cherrier Journal: Heart Date: 1997-03 Impact factor: 5.994
Authors: C Chirouze; E Athan; F Alla; V H Chu; G Ralph Corey; C Selton-Suty; M-L Erpelding; J M Miro; L Olaison; B Hoen Journal: Clin Microbiol Infect Date: 2013-03-20 Impact factor: 8.067
Authors: Eckhard Schmid; Jan N Hilberath; Gunnar Blumenstock; Prem S Shekar; Steffen Kling; Stanton K Shernan; Peter Rosenberger; Martina Nowak-Machen Journal: Heart Lung Vessel Date: 2015
Authors: Christian G Cornelissen; Dirk A Frechen; Karin Schreiner; Nikolaus Marx; Stefan Krüger Journal: BMC Infect Dis Date: 2013-06-15 Impact factor: 3.090
Authors: Ruchi Bhandari; Talia Alexander; Frank H Annie; Umar Kaleem; Affan Irfan; Sudarshan Balla; R Constance Wiener; Chris Cook; Aravinda Nanjundappa; Mark Bates; Ellen Thompson; Gordon S Smith; Judith Feinberg; Melanie A Fisher Journal: PLoS One Date: 2022-07-15 Impact factor: 3.752
Authors: Lennart Viezens; Marc Dreimann; André Strahl; Annika Heuer; Leon-Gordian Koepke; Benjamin Bay; Christoph Waldeyer; Martin Stangenberg Journal: Neurosurg Rev Date: 2021-09-11 Impact factor: 3.042
Authors: Sara Álvarez-Zaballos; Victor González-Ramallo; Eduard Quintana; Patricia Muñoz; Sofía de la Villa-Martínez; M Carmen Fariñas; Francisco Arnáiz-de Las Revillas; Arístides de Alarcón; M Ángeles Rodríguez-Esteban; José M Miró; Miguel Angel Goenaga; Josune Goikoetxea-Agirre; Elisa García-Vázquez; Lucía Boix-Palop; Manuel Martínez-Sellés Journal: J Clin Med Date: 2022-08-13 Impact factor: 4.964